It is well known that the immune cells in the tumor microenvironment (TME) can affect the survival time of the patients with distinct cancers, and the analysis results of the bioinformatics in the current study showed that the expression levels of FUNDC2 are associated with the survival of multifarious cancer patients, indicating a potential prognostic effect of FUNDC2 in pan-cancer (Fig 2). The gene discussed is FUNDC2; the disease is cancer.